Purpose The aim of this study was to evaluate the efficacy and tolerability of
rosuvastatin/ezetimibe combination therapy in Korean patients with high cardiovascular risk.
Methods This was a 12-week, randomized, double-blind, placebo-controlled, multicenter
study. A total of 337 patients were screened. After a 4-week run-in period, 245 of these
patients with high or moderately high risk as defined by the National Cholesterol Education
Program Adult Treatment Panel III guidelines were randomly assigned. Patients received 1 …